Akebia Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Akebia Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q2 2024.
  • Akebia Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 210M shares, a 11.6% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 210M +21.8M +11.6% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 209M +23.6M +12.7% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 195M +10.4M +5.67% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 188M +4.36M +2.37% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 188M +4.42M +2.41% Jun 30, 2023 10-Q 2023-08-28
Q1 2023 186M +2.45M +1.34% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 184M +7.13M +4.03% Dec 31, 2022 10-K 2024-03-14
Q3 2022 184M +9.4M +5.39% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 184M +14.1M +8.28% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 183M +24.9M +15.7% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 177M +28.9M +19.5% Dec 31, 2021 10-K/A 2023-08-28
Q3 2021 175M +31.2M +21.8% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 170M +26.5M +18.5% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 159M +28.3M +21.7% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 148M +26.4M +21.7% Dec 31, 2020 10-K 2022-03-01
Q3 2020 143M +24.5M +20.6% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 143M +24.3M +20.5% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 130M +13.1M +11.2% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 122M +4.79M +4.1% Dec 31, 2019 10-K 2021-02-25
Q3 2019 119M +61.8M +108% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 119M +61.9M +109% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 117M +60.3M +106% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 117M +69.3M +145% Dec 31, 2018 10-K 2020-03-12
Q3 2018 57M +9.81M +20.8% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 56.9M +14.4M +33.9% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 56.9M +18M +46.4% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 47.6M +9M +23.3% Dec 31, 2017 10-K 2019-03-26
Q3 2017 47.2M +8.98M +23.5% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 42.5M +4.48M +11.8% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 38.8M +884K +2.33% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 38.6M +7.95M +25.9% Dec 31, 2016 10-K 2018-03-12
Q3 2016 38.3M +8.04M +26.6% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 38M +9.13M +31.6% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 37.9M +17.5M +85.3% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 30.7M +10.3M +50.5% Dec 31, 2015 10-K 2017-03-06
Q3 2015 30.2M +9.92M +48.9% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 28.9M +8.62M +42.5% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 20.5M +211K +1.04% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 20.4M +19M +1373% Dec 31, 2014 10-K 2016-03-14
Q3 2014 20.3M Sep 30, 2014 10-Q 2014-11-10
Q2 2014 20.3M Jun 30, 2014 10-Q 2014-08-11
Q1 2014 20.3M Mar 31, 2014 10-Q 2014-05-12
Q4 2013 1.38M Dec 31, 2013 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.